DM
FOMX

Deerfield Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Deerfield Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-234,745
Closed -$1.34M – 115
2018
Q3 		$1.34M Sell
234,745
-439,257
-65% -$2.51M 0.05% 100
2018
Q2 		$3.38M Hold
674,002
– – 0.12% 103
2018
Q1 		$3.46M Buy
674,002
+173,002
+35% +$1.04M 0.12% 101
2017
Q4 		$3.01M Sell
501,000
-316,435
-39% -$1.9M 0.12% 87
2017
Q3 		$4.54M Hold
817,435
– – 0.2% 80
2017
Q2 		$3.79M Hold
817,435
– – 0.2% 71
2017
Q1 		$4.05M Sell
817,435
-415,409
-34% -$4M 0.16% 89
2016
Q4 		$13.7M Sell
1,232,844
-74,214
-6% -$698K 0.56% 54
2016
Q3 		$12.1M Buy
1,307,058
+25,000
+2% +$209K 0.56% 44
2016
Q2 		$8.14M Buy
1,282,058
+333,124
+35% +$2.21M 0.32% 60
2016
Q1 		$6.19M Hold
948,934
– – 0.26% 66
2015
Q4 		$7.7M Hold
948,934
– – 0.31% 69
2015
Q3 		$6.96M Hold
948,934
– – 0.27% 80
2015
Q2 		$9.73M Buy
948,934
+269,307
+40% +$2.98M 0.32% 72
2015
Q1 		$6.29M Sell
679,627
-65,172
-9% -$583K 0.2% 79
2014
Q4 		$5.22M Buy
744,799
+298,347
+67% +$1.71M 0.19% 80
2014
Q3 		$2.43M Buy
+446,452
New +$2.56M 0.09% 108

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Deerfield Management's FOMX Position: Q4 2018 in Review

Deerfield Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2018, closing a stake of 234,745 shares — an estimated $1.34M sold.

Deerfield Management first reported a position in FOMX in Q3 2014 and held it in 17 quarters. The position peaked at $13.7M in Q4 2016. 66 funds tracked by Wall St. Rank hold FOMX as of Q4 2018.

  • Deerfield Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • Deerfield Management sold 234,745 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2018, an estimated $1.34M.
  • Deerfield Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 17 quarters.
  • Deerfield Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $13.7M in Q4 2016.
  • 66 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2018.

Based on Deerfield Management's 13F filing for Q4 2018, filed 14 Feb 2019.